Search for early warning signs of Chemotherapy's heart risk
NCT ID NCT04036045
Summary
This study aimed to find early warning signs of heart damage in children and young adults receiving a common type of chemotherapy drug called anthracyclines. Researchers planned to use blood tests and heart scans to look for tiny markers that might predict which patients are most at risk. The goal was to gather knowledge to help protect patients' hearts in the future, but the study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDHOOD CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Olga Salazar
Hartford, Connecticut, 06106, United States
Conditions
Explore the condition pages connected to this study.